According to a Future Market Insights (FMI) analysis, the High Flow Oxygen Therapy Devices Market size was held at around US$ 1.7 billion in 2021. Overall sales of High Flow Oxygen Therapy Devices are predicted to reach US$ 1.4 billion by 2031, with a -2.0% CAGR from 2021 to 2031. With the rising prevalence of …
Category Archives: Healthcare Trends
Disposable Medical Gowns Market in China is projected to expand at a CAGR of around 30.7% during 2022 to 2032
According to a recently published analytical report by Future Market Insights, the global Disposable Medical Gowns Market recorded sales of US$2.5 billion in 2021. The anticipated market growth from 2022 to 2032 is anticipated to be substantially larger than the increase in the past, coming in at 17.5%. With the latest insights and statistics from …
Biodegradable Gloves Market is expected to reach US$ 10.2 Billion by 2032 with sales revenue expected to register a 23.0% CAGR
The global Biodegradable Gloves Market stands at US$ 1.3 Billion as of now and is expected to reach US$ 10.2 Billion by the year 2032 at a staggering CAGR of 23% between 2022 and 2032. Rubber gloves hold the largest market share; as far as gloves market is concerned. Latex products have been known as …
AI-based Clinical Trials Solution Provider Market is expected to reach a valuation of US$ 14.2 Billion by 2032 expanding at a CAGR of 23.2%
During the projection period of 2022–2032, the global AI-based Clinical Trials Solution Provider Market is projected to increase at a CAGR of 23.2%, from US$ 1.7 billion in 2022 to US$ 14.2 billion by 2032. Future Market Insights, a market research, and competitive intelligence provider, analyses that AI-based Clinical Trials Solution Provider market is set …
IV Therapy And Vein Access Devices Market is likely to propel to US$ 44.4 Billion by 2032 at a 5.6% CAGR
According to a report recently released by Future Market Insights, the global IV Therapy And Vein Access Devices Market is expected to generate US$ 44.4 billion while exhibiting a 5.6% CAGR over the forecast period. In the upcoming years, market expansion is probably going to be fueled by the increasing backing from several governments. In …
Diabetic Retinopathy Market is expected to be valued at US$ 14.8 Billion by 2032 register a CAGR of 5.8%
The Diabetic Retinopathy Market is anticipated to reach US$ 14.8 billion by 2032 and grow at a 5.8% CAGR during the projected period. (2022 – 2032). Future Market Insights (FMI) caters to all the needs of the clients working in the international healthcare, pharmaceutical, and medical device industries with its 1000+ market research studies and …
Healthcare Biometrics Market is expected to be valued at US$ 17.9 Billion by 2032 register a CAGR of 18.1%
The Healthcare Biometrics Market to Reach US$ 17.9 Billion by 2032, owing to the Increasing number of Healthcare Fraud; Healthcare Biometrics Market to Record an 18.1% CAGR through 2032. The demand for healthcare biometrics is likely to rise as the number of healthcare frauds is rising all around the globe and the advancement of new technology brings the …
Brain Monitoring Systems Market is projected to cross a value of US$ 8.5 billion by 2033 | FMI Study
The brain monitoring systems market is projected to expand at a healthy pace with global sales exceeding US$ 3.5 Bn by end of 2019, as per the latest research study by FMI. A range of broad factors, including the government funding for development of advanced medical devices, and favorable healthcare reimbursements are key sales influencers of brain …
Endometriosis Treatment Market size is expected to cross US$ 3.55 Billion by 2032 | Exclusive Report by FMI
Increasing investments in the endometriosis treatment market by key stakeholders and rising awareness among women are the major factors expected to drive market growth. The global endometriosis treatment market was valued at US$ 2.8 Bn in 2018, and is expected to exhibit a CAGR of around 3% over the forecast period (2019-2030). Rising prevalence of endometriosis condition …
Therapeutic Nuclear Medicines Market is expected to increase from a valuation of US$ 1 Billion in 2022 | FMI
Increasing acceptance of therapeutic nuclear medicines (or radiopharmaceuticals) among industry experts will remain a prominent factor in encouraging their adoption. Though associated with a negligible risk factor, radiopharmaceuticals are likely to witness growing recommendations owing to no proven significant adverse effects. In the backdrop of the growing criticality of a more reliable, safer, and lesser …